Atrial fibrillation
Conditions
Interventions
None listed
Sponsors
Department of Cardiology University Northern Yokohama Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) Patients who have given written consent to this study 2) Patients aged 18 to 85 3) Patients with persistent atrial fibrillation with a duration of 1 week or more and who desire drug resistance or catheter ablation
Exclusion criteria
Exclusion criteria: 1) Patients who cannot undergo catheter ablation due to anticoagulant therapy or intracardiac thrombosis 2) Patients who are unable to return to sinus rhythm Patients with a history of ablation for atrial fibrillation or atypical atrial flutter. 3) Patients after the Maze procedure. 4) Patients undergoing implantable cardiac device (pacemaker, ICD) treatment. 5) Patients who have taken amiodarone within the past year. 6) Untreated hyperthyroidism or hypothyroidism. 7) Patients with end-stage renal disease (patients with eGFR less than 15 or requiring dialysis therapy). 8) Other patients who the doctor judged not to be indicated for this study (patients who are anatomically considered to be difficult to use CARTO FINDER)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Comparison of local atrial fibrillation origins identified by a new 3D mapping algorithm | — |
Secondary
| Measure | Time frame |
|---|---|
| Comparison of local atrial fibrillation origins identified by a novel 3D mapping algorithm at the time of recurrence | — |
Countries
Japan
Contacts
Public ContactMorio Ono
Showa University Northern Yokohama Hospital Cardiology
Outcome results
None listed